Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Shasun Pharmaceuticals to sell Vizag plant
7:03 AM MST | December 12, 2013 | Natasha Alperowicz
Shasun Pharmaceuticals (Chennai, India), a leading global supplier of intermediates, active pharma ingredients (APIs) and formulations, announced today that its board of directors has approved plans to divest its Vizag, India, manufacturing facility subject to approval from shareholders. The company announced in 2009 that it plans to build the facility with an initial production capacity of 1,200 m.t./year of bulk drugs, including generic APIs, particularly for the Japanese market. Completion of the facility was delayed several times due to several reasons...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee